현기증 치료 시장 규모, 점유율, 성장 분석 : 유형별, 치료법별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Vertigo Treatment Market Size, Share, and Growth Analysis, By Type (Benign Paroxysmal Positional Vertigo (BPPV), Labyrinthitis), By Treatment (Anticholinergics, Antihistamines), By End User, By Region - Industry Forecast 2025-2032
상품코드:1687633
리서치사:SkyQuest
발행일:2025년 03월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 현기증 치료 시장 규모는 2023년에 18억 3,000만 달러로 평가되며, 2024년 19억 2,000만 달러에서 2032년에는 28억 6,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 5.1%로 성장할 전망입니다.
회전 및 이동 감각을 특징으로 하는 어지럼증은 전 세계에서 개인에게 미치는 영향이 확대되고 있으며, 어지럼증 치료 시장에 대한 수요가 급증하고 있습니다. 이러한 추세는 어지럼증 유병률 증가와 의료비 지출 증가가 주요 요인으로 작용하고 있습니다. 또한 고령화 사회가 확대됨에 따라 특히 노인 인구가 많은 국가에서는 현기증의 위험이 증가하고 있습니다. 어지럼증의 증상과 치료에 대한 인식이 높아지고 의학 연구에 대한 투자가 증가함에 따라 장기적인 시장 성장이 기대됩니다. 또한 잘못된 생활 습관의 확산은 효과적인 어지럼증 치료에 대한 수요를 촉진하고 있습니다. 이러한 요인들을 종합하면 빠르게 진화하는 의료 환경에서 어지럼증 치료제를 제공하는 기업에게 유망한 비즈니스 기회가 될 수 있습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
사례 연구
규제 상황
특허 분석
현기증 치료 시장 규모 : 유형별 & CAGR(2025-2032)
시장 개요
BPPV(Benign Paroxysmal Positional Vertigo)
내이염
전정 신경염
메니에르병
현기증 치료 시장 규모 : 치료법별 & CAGR(2025-2032)
시장 개요
항콜린제
항히스타민약
벤조디아제핀
기타
현기증 치료 시장 규모 : 최종사용자별 & CAGR(2025-2032)
시장 개요
병원
클리닉
기타
현기증 치료 시장 규모 : 지역별 & CAGR(2025-2032)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
기업의 상세
제품 포트폴리오 분석
기업의 부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
Pfizer Inc.(USA)
Novartis AG(Switzerland)
Abbott Laboratories(USA)
Teva Pharmaceutical Industries Ltd.(Israel)
Bayer AG(Germany)
GlaxoSmithKline plc(UK)
Merck & Co., Inc.(USA)
Johnson & Johnson(USA)
Eli Lilly and Company(USA)
Boehringer Ingelheim GmbH(Germany)
AstraZeneca plc(UK)
Bristol-Myers Squibb Company(USA)
Takeda Pharmaceutical Company Limited(Japan)
Astellas Pharma Inc.(Japan)
Otsuka Pharmaceutical Co., Ltd.(Japan)
Sun Pharmaceutical Industries Ltd.(India)
Dr. Reddy's Laboratories Ltd.(India)
Cipla Limited(India)
Lupin Limited(India)
결론과 제안
KSA
영문 목차
영문목차
Global Vertigo Treatment Market size was valued at USD 1.83 billion in 2023 and is poised to grow from USD 1.92 billion in 2024 to USD 2.86 billion by 2032, growing at a CAGR of 5.1% during the forecast period (2025-2032).
Vertigo, characterized by sensations of spinning or movement, is increasingly affecting individuals globally, prompting a surging demand in the vertigo treatment market. This trend is largely driven by the rising incidence of vertigo and escalating healthcare expenditures. Additionally, as the aging population expands, the risk of vertigo intensifies, particularly in countries with significant elderly demographics. Increased awareness of vertigo symptoms and treatments, alongside growing investments in medical research, is expected to bolster market growth in the long-term. Furthermore, the prevalence of poor lifestyle habits is fueling the demand for effective vertigo treatments. Collectively, these factors present promising opportunities for vertigo treatment providers in a rapidly evolving healthcare landscape.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vertigo Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Vertigo Treatment Market Segments Analysis
Global Vertigo Treatment Market is segmented by Type, Treatment, End User and region. Based on Type, the market is segmented into Benign Paroxysmal Positional Vertigo (BPPV), Labyrinthitis, Vestibular Neuronitis and Meniere's Disease. Based on Treatment, the market is segmented into Anticholinergics, Antihistamines, Benzodiazepines and Others. Based on End User, the market is segmented into Hospitals, Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Vertigo Treatment Market
The global vertigo treatment market is significantly influenced by the increasing number of elderly individuals worldwide. As the aging population grows, so does the likelihood of experiencing vertigo, making this demographic a crucial driver of demand for vertigo treatments. With a higher incidence of vertigo associated with advancing age, healthcare providers are compelled to address the needs of this expanding geriatric population. This trend underscores the importance of developing effective treatment options and healthcare solutions tailored to the aging demographic, ultimately contributing to the overall growth of the market for vertigo treatments on a global scale.
Restraints in the Global Vertigo Treatment Market
The Global Vertigo Treatment market faces significant challenges due to the potential side effects associated with vertigo medications, which may include constipation, dizziness, insomnia, headaches, and fatigue. These adverse reactions can deter individuals from seeking pharmacological treatment for their condition, leading to reluctance in medication adherence and overall treatment. As a result, patients may opt for alternative therapies or choose to forego treatment altogether, which can restrict market growth and limit the adoption of effective solutions. Addressing these concerns is crucial for improving patient compliance and expanding the reach of vertigo treatment options in the global market.
Market Trends of the Global Vertigo Treatment Market
The Global Vertigo Treatment market is experiencing a significant shift towards novel diagnostic and drug delivery innovations, driving its growth. As advancements in diagnostic technologies emerge, companies are harnessing these tools to enhance accuracy and efficiency in identifying vertigo causes, ultimately boosting revenue potential. In addition, the adoption of cutting-edge drug delivery methods is gaining traction among treatment providers, enabling targeted medication delivery that minimizes side effects and maximizes therapeutic efficacy. This trend reflects the industry's commitment to improving patient outcomes and optimizing treatment protocols, positioning the market for sustained growth and responsiveness to evolving healthcare demands through 2023 and beyond.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Patent Analysis
Global Vertigo Treatment Market Size by Type & CAGR (2025-2032)
Market Overview
Benign Paroxysmal Positional Vertigo (BPPV)
Labyrinthitis
Vestibular Neuronitis
Meniere's Disease
Global Vertigo Treatment Market Size by Treatment & CAGR (2025-2032)
Market Overview
Anticholinergics
Antihistamines
Benzodiazepines
Others
Global Vertigo Treatment Market Size by End User & CAGR (2025-2032)
Market Overview
Hospitals
Clinics
Others
Global Vertigo Treatment Market Size & CAGR (2025-2032)
